Evidence map›Paper›PMID 41155982›Full record

ArticlePharmaceutics2025

Design of Polycation-Functionalized Resveratrol Nanocrystals for Intranasal Administration.

Angela Bonaccorso, Elide Zingale, Giuseppe Caruso, Anna Privitera, Claudia Carbone, Maria Josè Lo Faro, Filippo Caraci, Teresa Musumeci, Rosario Pignatello

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceutics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Angela BonaccorsoDepartment of Drug and Health Sciences, University of Catania, 95125 Catania, Italy.ORCID 0000-0002-3392-1258
Elide ZingaleDepartment of Drug and Health Sciences, University of Catania, 95125 Catania, Italy.ORCID 0000-0002-0035-9457
Giuseppe CarusoDepartmental Faculty of Medicine, UniCamillus-Saint Camillus International University of Health and Medical Sciences, 00131 Rome, Italy.ORCID 0000-0003-1571-5327
Anna PriviteraDepartment of Drug and Health Sciences, University of Catania, 95125 Catania, Italy.ORCID 0000-0003-2919-6150
Claudia CarboneDepartment of Drug and Health Sciences, University of Catania, 95125 Catania, Italy.ORCID 0000-0003-3592-752X
Maria Josè Lo FaroDipartimento di Fisica e Astronomia "Ettore Majorana", University of Catania, 95123 Catania, Italy.ORCID 0000-0002-2067-1608
Filippo CaraciDepartment of Drug and Health Sciences, University of Catania, 95125 Catania, Italy.
Teresa MusumeciDepartment of Drug and Health Sciences, University of Catania, 95125 Catania, Italy.ORCID 0000-0003-2299-7780
Rosario PignatelloDepartment of Drug and Health Sciences, University of Catania, 95125 Catania, Italy.ORCID 0000-0002-5937-4192

Funding

European Union - NextGenerationEU through the Italian Ministry of University and Research under PNRR the M4C2-I1.3 Project PE_00000019 "HEAL ITALIA" Unict CUP E63C22002080006Italian Min¬istry of Research [Grant PRIN 2022 - Tackling neurodegeneration with by-product-base-nanohydrogels for the nose-to-brain-delivery of natural bioactive compounds (TANDEM)] CUP 57723172011
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

cell viabilitynanotechnologynatural compoundnose-to-brainquality by design

Identifiers

PMID41155982
PMCPMC12566871

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.